Progyny (PGNY) Competitors $23.23 +0.43 (+1.89%) Closing price 04:00 PM EasternExtended Trading$22.94 -0.30 (-1.27%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PGNY vs. HIMS, GH, OPCH, RDNT, SHC, WGS, BTSG, PRVA, CON, and SGRYShould you be buying Progyny stock or one of its competitors? The main competitors of Progyny include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), GeneDx (WGS), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. Progyny vs. Hims & Hers Health Guardant Health Option Care Health RadNet Sotera Health GeneDx BrightSpring Health Services Privia Health Group Concentra Group Holdings Parent Surgery Partners Hims & Hers Health (NYSE:HIMS) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, community ranking, dividends, valuation, profitability, earnings, institutional ownership and media sentiment. Which has higher valuation and earnings, HIMS or PGNY? Progyny has lower revenue, but higher earnings than Hims & Hers Health. Progyny is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B6.17-$23.55M$0.5475.89Progyny$1.17B1.70$62.04M$0.5740.75 Which has more risk and volatility, HIMS or PGNY? Hims & Hers Health has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Do institutionals & insiders have more ownership in HIMS or PGNY? 63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 94.9% of Progyny shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by company insiders. Comparatively, 9.4% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is HIMS or PGNY more profitable? Hims & Hers Health has a net margin of 8.19% compared to Progyny's net margin of 5.03%. Progyny's return on equity of 11.36% beat Hims & Hers Health's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% Progyny 5.03%11.36%7.87% Does the MarketBeat Community favor HIMS or PGNY? Progyny received 59 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 70.83% of users gave Progyny an outperform vote while only 35.25% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes4335.25% Underperform Votes7964.75% ProgynyOutperform Votes10270.83% Underperform Votes4229.17% Does the media prefer HIMS or PGNY? In the previous week, Hims & Hers Health had 53 more articles in the media than Progyny. MarketBeat recorded 58 mentions for Hims & Hers Health and 5 mentions for Progyny. Progyny's average media sentiment score of 1.54 beat Hims & Hers Health's score of 0.68 indicating that Progyny is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 26 Very Positive mention(s) 8 Positive mention(s) 14 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Progyny 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts prefer HIMS or PGNY? Hims & Hers Health currently has a consensus price target of $36.92, suggesting a potential downside of 9.92%. Progyny has a consensus price target of $23.64, suggesting a potential upside of 1.75%. Given Progyny's stronger consensus rating and higher possible upside, analysts plainly believe Progyny is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 2 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.08Progyny 0 Sell rating(s) 8 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.38 SummaryProgyny beats Hims & Hers Health on 10 of the 18 factors compared between the two stocks. Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PGNY vs. The Competition Export to ExcelMetricProgynyhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.99B$2.02B$5.56B$8.04BDividend YieldN/A7.12%5.09%4.22%P/E Ratio40.0516.3222.6818.83Price / Sales1.703.88404.28106.72Price / Cash35.589.3238.1834.62Price / Book4.034.046.794.33Net Income$62.04M$87.49M$3.22B$247.97M7 Day Performance2.07%1.42%2.44%2.71%1 Month Performance1.09%-4.98%3.78%3.37%1 Year Performance-27.56%-25.76%17.05%5.80% Progyny Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PGNYProgyny1.0706 of 5 stars$23.23+1.9%$23.64+1.7%-29.4%$1.99B$1.17B40.05310Upcoming EarningsPositive NewsHIMSHims & Hers Health2.4125 of 5 stars$28.51+1.5%$38.08+33.6%+191.3%$6.33B$1.48B64.80650Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageHigh Trading VolumeGHGuardant Health4.5367 of 5 stars$47.99-0.6%$49.00+2.1%+167.6%$5.92B$739.02M-13.481,790Earnings ReportAnalyst ForecastNews CoverageOPCHOption Care Health3.1849 of 5 stars$32.97+0.2%$33.75+2.4%+7.3%$5.42B$5.00B27.715,600Earnings ReportAnalyst UpgradeAnalyst RevisionNews CoveragePositive NewsRDNTRadNet4.0641 of 5 stars$51.03+1.5%$69.75+36.7%+3.5%$3.78B$1.83B-728.908,970Positive NewsSHCSotera Health1.6036 of 5 stars$11.26+0.9%$15.20+35.0%+7.4%$3.20B$1.10B45.043,000Earnings ReportNews CoverageWGSGeneDx2.8754 of 5 stars$112.49+1.3%$72.33-35.7%+197.9%$3.16B$305.45M-57.391,200Earnings ReportAnalyst ForecastInsider TradeNews CoverageGap UpBTSGBrightSpring Health Services1.6199 of 5 stars$17.31+2.3%$21.67+25.2%+67.9%$3.03B$11.27B-66.5835,000Earnings ReportNews CoveragePositive NewsGap UpPRVAPrivia Health Group4.0228 of 5 stars$23.20+0.1%$27.14+17.0%+27.0%$2.81B$1.74B232.02810Upcoming EarningsInsider TradeShort Interest ↓Positive NewsCONConcentra Group Holdings ParentN/A$21.64+1.8%$28.50+31.7%N/A$2.76B$1.90B14.3311,000Upcoming EarningsNews CoveragePositive NewsSGRYSurgery Partners3.2819 of 5 stars$21.56+0.4%$34.75+61.2%-8.9%$2.75B$3.11B-44.9212,200News Coverage Related Companies and Tools Related Companies Hims & Hers Health Alternatives Guardant Health Alternatives Option Care Health Alternatives RadNet Alternatives Sotera Health Alternatives GeneDx Alternatives BrightSpring Health Services Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives Surgery Partners Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PGNY) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
